Ramsay Health Care stock trims dilution after 220,000 rights lapse

Published on 10/08/2026 at 04:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ramsay Health Care stock was AUD 54.60 on the ASX on October 8, 2026, while more than 220,000 performance rights lapsed. FY26 underlying profit rose 19.3 percent.

Ramsay, AU000000RHC8, Illustration mit AI erstellt.

Ramsay Health Care (AU000000RHC8) was trading at AUD 54.60 on the ASX on October 8, 2026, at 12:48 p.m. AEDT, up 0.10 percent from the prior close. The latest company-specific event is the lapse of more than 220,000 performance rights, which prevents the related shares from being issued.

Performance rights reduce dilution

According to The Globe and Mail on October 2, 2026, the lapsed rights covered awards that were not satisfied or became incapable of being met between late July and early September. The update does not disclose the targets that were missed, but it removes the prospect of those particular awards becoming new shares.

That matters because the event addresses potential equity dilution rather than operating performance. Ramsay's underlying FY26 results provide the stronger earnings benchmark: underlying net profit after tax increased 19.3 percent year over year to AUD 364.1 million, according to TheBull in its FY26 coverage.

FY26 profit grew faster than revenue

For the fiscal year ended June 30, 2026, revenue reached AUD 18.6 billion, while underlying EBIT rose 11.8 percent to AUD 1.16 billion. The same FY26 figures show a 13.8 percent increase in the full-year dividend to AUD 0.91 per share, giving investors a clear comparison between earnings growth and shareholder distributions.

Analyst expectations remain more cautious than the profit trend. Investing.com reports a Neutral consensus from 15 analysts, including 4 Buy, 10 Hold and 1 Sell ratings, with an average 12-month target of AUD 51.93, a high of AUD 66.00 and a low of AUD 41.90. The average target sits below the October 8 intraday price, placing valuation rather than the lapsed awards at the center of the market debate.

Ramsay stock trades below its yearly high

Ramsay Health Care stock was trading at AUD 54.60 on the ASX on October 8, 2026, with a session range of AUD 54.33 to AUD 54.77. Its 52-week range was AUD 30.39 to AUD 55.98, leaving the share price 2.46 percent below the yearly high.